Login / Signup

Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertension.

Hironari HanaokaSho IshigakiHiroshi TakeiKazuoto HiramotoShuntaro SaitoYasushi KondoJun KikuchiYuko KanekoTsutomu Takeuchi
Published in: International journal of rheumatic diseases (2021)
Early combination therapy is associated with a lower incidence of CKD progression in patients with CTD-associated PH.
Keyphrases
  • pulmonary hypertension
  • combination therapy
  • pulmonary artery
  • pulmonary arterial hypertension
  • chronic kidney disease
  • coronary artery